BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 23684612)

  • 1. The Ets transcription factor GABP is a component of the hippo pathway essential for growth and antioxidant defense.
    Wu H; Xiao Y; Zhang S; Ji S; Wei L; Fan F; Geng J; Tian J; Sun X; Qin F; Jin C; Lin J; Yin ZY; Zhang T; Luo L; Li Y; Song S; Lin SC; Deng X; Camargo F; Avruch J; Chen L; Zhou D
    Cell Rep; 2013 May; 3(5):1663-77. PubMed ID: 23684612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
    Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
    J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABP cooperates with c-Myb and C/EBP to activate the neutrophil elastase promoter.
    Nuchprayoon I; Simkevich CP; Luo M; Friedman AD; Rosmarin AG
    Blood; 1997 Jun; 89(12):4546-54. PubMed ID: 9192779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.
    Irie K; Nagai T; Mizuno K
    J Biol Chem; 2020 Mar; 295(10):3017-3028. PubMed ID: 31996378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubule-Specific Mst1/2 Deficiency Induces CKD
    Xu C; Wang L; Zhang Y; Li W; Li J; Wang Y; Meng C; Qin J; Zheng ZH; Lan HY; Mak KK; Huang Y; Xia Y
    J Am Soc Nephrol; 2020 May; 31(5):946-961. PubMed ID: 32253273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.
    Meng Z; Moroishi T; Mottier-Pavie V; Plouffe SW; Hansen CG; Hong AW; Park HW; Mo JS; Lu W; Lu S; Flores F; Yu FX; Halder G; Guan KL
    Nat Commun; 2015 Oct; 6():8357. PubMed ID: 26437443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals.
    Moleirinho S; Chang N; Sims AH; Tilston-Lünel AM; Angus L; Steele A; Boswell V; Barnett SC; Ormandy C; Faratian D; Gunn-Moore FJ; Reynolds PA
    Oncogene; 2013 Apr; 32(14):1821-30. PubMed ID: 22614006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration.
    Grijalva JL; Huizenga M; Mueller K; Rodriguez S; Brazzo J; Camargo F; Sadri-Vakili G; Vakili K
    Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G196-204. PubMed ID: 24875096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma.
    Kong F; Li Y; Hu E; Wang R; Wang J; Liu J; Zhang J; He D; Xiao X
    PLoS One; 2016; 11(12):e0167080. PubMed ID: 27907036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raf-1 kinase targets GA-binding protein in transcriptional regulation of the human immunodeficiency virus type 1 promoter.
    Flory E; Hoffmeyer A; Smola U; Rapp UR; Bruder JT
    J Virol; 1996 Apr; 70(4):2260-8. PubMed ID: 8642652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liraglutide suppresses proliferation and induces adipogenic differentiation of 3T3-L1 cells via the Hippo-YAP signaling pathway.
    Li Y; Du J; Zhu E; Zhang J; Han J; Zhao W; Sun B; Tian D
    Mol Med Rep; 2018 Mar; 17(3):4499-4507. PubMed ID: 29344656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis.
    Wu H; Wei L; Fan F; Ji S; Zhang S; Geng J; Hong L; Fan X; Chen Q; Tian J; Jiang M; Sun X; Jin C; Yin ZY; Liu Q; Zhang J; Qin F; Lin KH; Yu JS; Deng X; Wang HR; Zhao B; Johnson RL; Chen L; Zhou D
    Nat Commun; 2015 Feb; 6():6239. PubMed ID: 25695629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma.
    Kim W; Khan SK; Liu Y; Xu R; Park O; He Y; Cha B; Gao B; Yang Y
    Gut; 2018 Sep; 67(9):1692-1703. PubMed ID: 28866620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
    J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGFR4 promotes nuclear localization of GABP to inhibit cell apoptosis in uterine leiomyosarcoma.
    Zhang P; Zhang H; Wang Y
    Cell Tissue Res; 2021 Feb; 383(2):865-879. PubMed ID: 33151453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippo signaling regulates pancreas development through inactivation of Yap.
    George NM; Day CE; Boerner BP; Johnson RL; Sarvetnick NE
    Mol Cell Biol; 2012 Dec; 32(24):5116-28. PubMed ID: 23071096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance.
    Zhou D; Zhang Y; Wu H; Barry E; Yin Y; Lawrence E; Dawson D; Willis JE; Markowitz SD; Camargo FD; Avruch J
    Proc Natl Acad Sci U S A; 2011 Dec; 108(49):E1312-20. PubMed ID: 22042863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperative regulation of Fc receptor gamma-chain gene expression by multiple transcription factors, including Sp1, GABP, and Elf-1.
    Takahashi K; Hayashi N; Shimokawa T; Umehara N; Kaminogawa S; Ra C
    J Biol Chem; 2008 May; 283(22):15134-41. PubMed ID: 18378679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
    Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
    Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.
    Liu J; Li J; Li P; Wang Y; Liang Z; Jiang Y; Li J; Feng C; Wang R; Chen H; Zhou C; Zhang J; Yang J; Liu P
    Sci Rep; 2017 Feb; 7():42125. PubMed ID: 28169360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.